List of Tolak drug patents
Tolak is owned by Hill Dermaceuticals.
Tolak contains Fluorouracil.
Tolak has a total of 1 drug patent out of which 0 drug patents have expired.
Tolak was authorised for market use on 18 September, 2015.
Tolak is available in cream;topical dosage forms.
The generics of Tolak are possible to be released after 18 July, 2023.
| Patent Number | Company | Patent Title | Patent Expiry | Activity Alert |
|---|---|---|---|---|
| These patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc). | ||||
| US7169401 | HILL DERMACEUTICALS | Topical skin care composition containing refined peanut oil |
Jul, 2023
(3 months from now) | |
Drugs and Companies using FLUOROURACIL ingredient
Market Authorisation Date: 18 September, 2015
Treatment: NA
Dosage: CREAM;TOPICAL
More Information on Dosage
TOLAK family patents
5
United States
1
Canada
1
European Union
900+ leading pharmaceutical companies are staying up-to-date with drug patents through Pharsight
Join them to stay ahead in capturing the next drug going generic